Jeremy P. Harris

ORCID: 0000-0001-7603-0263
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Cancer Studies
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Palliative Care and End-of-Life Issues
  • International Relations in Latin America
  • Head and Neck Surgical Oncology
  • Advanced Radiotherapy Techniques
  • Brain Metastases and Treatment
  • Cancer survivorship and care
  • Radiomics and Machine Learning in Medical Imaging
  • Sarcoma Diagnosis and Treatment
  • Migration and Labor Dynamics
  • Bone Tumor Diagnosis and Treatments
  • Immigration and Intercultural Education
  • Colorectal and Anal Carcinomas
  • Economic and Financial Impacts of Cancer
  • Cancer Immunotherapy and Biomarkers
  • Polyomavirus and related diseases
  • Cancer Genomics and Diagnostics
  • Nonmelanoma Skin Cancer Studies
  • Business, Innovation, and Economy
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Central Venous Catheters and Hemodialysis
  • Colorectal Cancer Treatments and Studies
  • Glioma Diagnosis and Treatment

University of California, Irvine
2020-2025

University of California, Irvine Medical Center
2021-2024

University of Toledo
2022

Cleveland Clinic
2022

Summa Health System
2022

Stanford Medicine
2016-2020

Cancer Institute (WIA)
2019

Stanford Cancer Institute
2019

Stanford University
2017-2019

Government of the United States of America
2015

Summary Background and objectives Comparisons of fistulas grafts often overlook the high primary failure rate fistulas. This study compared cumulative patency (time from access creation to permanent failure) grafts. Design, setting, participants, & measurements Vascular accesses 1140 hemodialysis patients two centers (Toronto London, Ontario, Canada, 2000−2010) were analyzed. Cumulative was between groups using Kaplan-Meier survival curves log-rank tests. Hazard ratios (HRs) for fistula...

10.2215/cjn.00730112 article EN Clinical Journal of the American Society of Nephrology 2013-02-01
Julia Scarisbrick Pietro Quaglino H. Miles Prince Evangelia Papadavid Emmilia Hodak and 95 more M. Bagot Octavio Servitje Emilio Berti Pablo L. Ortiz‐Romero Rudolf Stadler Aikaterini Patsatsi Robert Knobler Emmanuella Guenova Fiona Child Sean Whittaker Vasiliki Nikolaou Carlo Tomasini Iris Amitay Hadas Prag Naveh C. Ram‐Wolff Maxime Battistella Silvia Alberti Violetti R. Stranzenbach Vanessa Gargallo Cristina Muniesa Triantafyllia Κoletsa Constanze Jonak Stefanie Porkert Christina Mitteldorf Teresa Estrach Andrea Combalía Márta Marschalkó Judit Csomor Ágota Szepesi Antonio Cozzio Reinhard Dummer Nicola Pimpinelli Vieri Grandi M. Beylot‐Barry Anne Pham‐Ledard Marion Wobser Eva Geissinger Ulrike Wehkamp Michael Weichenthal Richard Cowan Eileen Parry Jeremy P. Harris Rachel Wachsmuth Deborah Turner Andrew Bates Eugene Healy Franz Trautinger Johanna Latzka Jungmin Yoo B. Vydianath Rasoul Amel-Kashipaz Leonidas Marinos A. Oikonomidi Alexander J. Stratigos Marie‐Dominique Vignon‐Pennamen Maxime Battistella Fina Climent Eva González‐Barca Elisavet Georgiou Rebecca Senetta Pier Luigi Zinzani Liisa Väkevä Annamari Ranki A.M. Busschots Esther Hauben An Bervoets F. J. Sherida H. Woei‐A‐Jin Rubeta Matin Graham P. Collins Sophie Weatherhead J. Frew M. Bayne Giles Dunnill Pam McKay Arvind Arumainathan Richard Azurdia Kim Benstead Robert Twigger Kerri E. Rieger Ryanne A. Brown José Antônio Sanches Denis Miyashiro Oleg E. Akilov Sue McCann Helka Sahi Fabiana Damasco Christiane Querfeld Amy Folkes Cecilia Bur C.‐D. Klemke Paula Enz Ramón M. Pujol Koen D. Quint Larisa J. Geskin Eric Hong

Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective Cutaneous Lymphoma International Prognostic Index) study a web-based data collection system for early-stage MF with legal data-sharing agreements permitting international collaboration rare cancer complex pathology. Clinicopathological must 100% complete in-built intelligence the database ensures accurate staging.

10.1111/bjd.17258 article EN British Journal of Dermatology 2018-09-29

The optimal management of local-regionally recurrent head and neck cancer that is not amenable to surgical resection uncertain. We sought compare outcomes among patients treated with without re-irradiation in this setting.

10.1016/j.radonc.2024.110278 article EN cc-by Radiotherapy and Oncology 2024-04-16

Randomized control trials and population-based studies do not demonstrate a definitive benefit for adjuvant chemotherapy (ACT) in stage II colon cancer (CC). Tumor sidedness microsatellite instability (MSI) status may predict response to ACT, but previous have limited data. We assessed the efficacy of ACT possible interaction with MSI tumor patients resected CC diagnosed between 2010 2013 using National Cancer Database.Overall survival was evaluated Kaplan-Meier method multivariate...

10.1097/coc.0000000000000554 article EN American Journal of Clinical Oncology 2019-06-05

Importance The role of surveillance imaging after treatment for head and neck cancer is controversial evidence to support decision-making limited. Objective To determine the use in asymptomatic patients with remission completion chemoradiation. Design, Setting, Participants This was a retrospective, comparative effectiveness research review adult who had achieved complete metabolic response initial as defined by having an unequivocally negative positron emission tomography (PET) scan using...

10.1001/jamanetworkopen.2023.42825 article EN cc-by-nc-nd JAMA Network Open 2023-11-10

Despite the recent approval of immune checkpoint inhibitors (ICIs), Merkel cell carcinoma (MCC) remains highly lethal for most patients failing out ICIs.1Nghiem P. Bhatia S. Lipson E.J. et al.Three-year survival, correlates and salvage therapies in receiving first-line pembrolizumab advanced carcinoma.J Immunother Cancer. 2021; 9e002478https://doi.org/10.1136/jitc-2021-002478Crossref Scopus (40) Google Scholar Existing biomarkers (tumor mutation burden, programmed death ligand-1 expression,...

10.1016/j.jaad.2022.03.020 article EN cc-by Journal of the American Academy of Dermatology 2022-03-19

10.1016/j.ijrobp.2024.02.054 article EN International Journal of Radiation Oncology*Biology*Physics 2024-06-14

Understanding healthcare providers' preferences, values, and beliefs around AVF eligibility is important to explain variability in practice. We conducted a survey of international surgeons, using hypothetical patient scenarios, assess resources used, variables, perceived barriers, absolute contraindications access creation. A total 134 surgeons completed the survey. Venous duplex ultrasound mapping (VDUM) was offered all patients by 90% US, 68% Canadian, 63% European respondents. VDUM...

10.1111/sdi.12046 article EN Seminars in Dialysis 2013-03-21

Endovascular repair of blunt traumatic thoracic aortic injuries (BTAI) is common at most trauma centres, with excellent results. However, little known regarding which do not require intervention. We reviewed the natural history untreated patients minimal injury (MAI) our centre.

10.1503/cjs.007311 article EN Canadian Journal of Surgery 2012-11-28

Objectives/Hypothesis To identify prognosticators and determine the efficacies of surgery with adjuvant radiotherapy (SR) immunotherapy (SI) head neck mucosal melanoma (HNMM). Study Design Retrospective database study. Methods The 2004 to 2017 National Cancer Database was queried for HNMM patients. Cox proportional hazards Kaplan‐Meier analyses evaluated mortality survival benefits conferred by SR, SI, or (SRI). Logistic regression identified predictors use. Results Overall, 1,910 cases (845...

10.1002/lary.29807 article EN The Laryngoscope 2021-08-06

Objective For patients with head and neck squamous cell carcinoma (HNSCC), delays in the initiation of radiotherapy (RT) have been closely associated worse outcomes. We sought to investigate whether RT modality (proton vs. photon) is differences time RT. Methods The National Cancer Database was queried for diagnosed nonmetastatic HNSCC between 2004 2015 who received either proton or photon as part their initial treatment. Wilcoxon rank‐sum chi‐square tests were used compare continuous...

10.1002/lary.28458 article EN The Laryngoscope 2019-12-14

To comprehensively investigate nasopharyngeal carcinoma (NPC) treatment, overall survival (OS), and the influence of clinical/sociodemographic factors on outcome.Retrospective database study.National Cancer Database.The 2004-2015 National Database was queried for all patients with NPC receiving definitive treatment. Log-rank tests Cox proportional hazards models were used statistical analyses.A total 8260 included (71.4% male; 42.5% keratinizing histology; mean ± SD age, 52.1 15.1 years), a...

10.1177/0194599820973241 article EN Otolaryngology 2020-11-24

Objectives Immunotherapy with immune checkpoint inhibitors has shown only limited success in the management of metastatic soft tissue sarcoma. Overall response rates (ORR) single agent pembrolizumab were 18% and median PFS was 18 weeks on clinical trial SARC028. One strategy to improve responses immunotherapy is stereotactic body radiation therapy (SBRT), which can enhance antitumor CD8 T cell through release tumor-specific antigens, potentially priming a more diverse class receptors....

10.1177/10732748241237331 article EN cc-by-nc Cancer Control 2024-01-01

Y-90 Selective Internal Radiotherapy (SIRT) is an ablative therapy used for inoperable liver metastasis. The purpose of this investigation was to examine the impact local control after SIRT on overall survival (OS) in oligometastatic patients. A retrospective, single-institution study identified patients with ≤5 non-intracranial metastases receiving unilateral or bilateral lobar from 2009 2021. primary endpoint OS defined completion date death last follow-up. Local failure classified as a...

10.3390/cancers16132401 article EN Cancers 2024-06-29
Coming Soon ...